Cholera vaccine

Details Cholera vaccine Cholera vaccine

1979-04-11

1982-05-04

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

435172, A61K 39106, C12N 1500, C12N 136, C12R 163

Patent

active

043282091

ABSTRACT:
Vibrio cholerae, Ogawa serotype, El Tor biotype, are subjected to the mutagenic N-methyl-N'-nitro-n-nitrosoguanidine (NTG). First generation mutants are screened for toxin production, and in particular the absence of "A" or enzymatically active subunit production and production of B (binding) subunit. Putative A.sup.- B.sup.+ mutants are again exposed to NTG and screened for the A.sup.- B.sup.+ characteristics. The formula of the native toxin molecule is usually A.sup.+ B.sup.+.sub.5-6, the formula for the molecule produced by the selected second generation mutant is A.sup.- B.sup.+.sub.5-6. This mutant strain is used for production of a live attenuated vaccine which can be administered orally. The mutant has been found to induce immunity, in an experimental model system, against subsequent challenge with virulent cholera vibrios. Because of the immunologic relationship to other enterotoxins (such as the heat-labile enterotoxin of Escherichia coli), the mutant may also induce immunity to diarrheal diseases other than cholera. In fact, antiserum to the isolated toxin-related protein produced by the mutant has been shown to neutralize E. coli entero-toxin. The mutant may also be used for the production of "choleragenoid", the non-toxic, highly immunogenic B portion of the cholera enterotoxin (choleragen) without the complication of toxicity associated with the complete enterotoxin.

REFERENCES:
patent: 3145144 (1964-08-01), Ando
patent: 3328253 (1967-06-01), Watanabe
patent: 3329573 (1967-07-01), Hoerlein
patent: 3972858 (1976-08-01), Stark et al.
patent: 4125492 (1978-11-01), Cautrecasas
patent: 4264737 (1981-04-01), Murphy
Finkelstein, "Cholera" CRC Critical Reviews in Microbiology, May 1973, pp. 553-623, Esp., pp. 589-590, F.N. 391-404, Genetic Regulation, 599, F.N. 489-506, Oral Living Attenuated Cholera Mutant Vaccine.
Woodward et al., Proc. 11th Joint Conf. Cholera U.S.-Japan Medical Science Program (1975), 330-335, "Efficacy of a Live Oral Cholera Vaccine in Human Volunteers".
Chem. Abstracts, vol. 89 (1978)-vol. 56 (1962), Index Entry "Vibrio-Comma (Cholera), Eltor".
Chem. Abstracts, vol. 89 (1978)-vol. 56 (1962), Index Entry "Guanidine, 1 Methyl-3 nitro-1-nitroso".
C.A. 89:204042n, 1010c88:131408d, 166344g (1978), 87:63410a (1977) 81:35454a (1974).
C.A. 80:44287e (1974), 77:143756(b), (1972), 72:63879a (1970), 55:16676, 15583 (1961).
Finkelstein et al., J. Exp. Med. 130:185-202, (1969), "Pathogenesis of Experimental Cholera".
Nelson et al., Inf. & Immun. 14(2):527-547, Aug. 1976 "Vibrio cholerae Adherence and Colonization in Experimental Cholera: Electron Microscopic Studies".
WO80/02504, Published with Amended claims, Dec. 11, 1980, PCT/US80/00613, Oeschger; Max et al., "Genetically Attenuated Bacterial Vaccines with Multiple Mutations of the Same Phonotype".
Clements, J. D.; Finkelstein, R. A., "Demonstration of Shared and Unique Immunological Determinants in Entero Toxins from Vibrio-cholerae and Escherichia-coli", Infect. Immun. (Infib), _V 22 (3), 1978, pp. 709-713, ISSN 00199567.
Clements, J. D.; Finkelstein, R. A., "Immunological Cross-Reactivity Between a Heat-Labile Entero Toxin(s) of Escherichia-coli and Subunits of Vibrio-cholerae Entero Toxin", Infect. Immun. (Infib), V 21 (3), 1978, pp. 1036-1040, ISSN 00199567.
Finkelstein, R. A.; Boesman-Finkelstein M., "Cholera and Related Diarrhoeas (`Turista`)", Nature 275 (5677): 173-174, Sep. 78.
Klapper, David G.; Finkelstein, R. A.; Capra, J. Donald, "Subunit Structure and N-Terminal Amino Acid Sequence of the Three Chains of Cholera Enterotoxin", Immunochemistry (IMCHZ), V 13 (7), pp. 605-611, 1976.
Finkelstein, R. A., "Cholera Enterotoxin", Microbiology (Washington, D. C.), (MICRDG); pp. 236-241, 1975.
Finkelstein, R. A., "Cholera Enterotoxin (Choleragen)", Jpn. J. Med. Sci. Biol. (JJMCAQ), V 28 (1), pp. 76-78, 1975.
Finkelstein, R. A.; Boesman, Mary; Neoh, Sim Hee; LaRue, Michael K.; Delaney, Robert, "Dissociation and Recombination of the Subunits of the Cholera Enterotoxin (Choleragen)", J. Immunol. (JOIMA3), V 113 (1), pp. 145-150, 1974.
Holmes, R. K.; Vasil, M. L.; Finkelstein, R. A., "Isolation and Preliminary Characterization of Nontoxinogenic Mutants of Vibrio-cholerae", Abstr. Annu. Meet. Am. Soc. Microbiol. (ASMAC), V 73, 1973:90.
Peterson, J. W.; Lo Spalluto, J. J.; Finkelstein, R. A., "Localization of Cholera Toxin In-Vivo", J. Infect. Dis. (JIDIA), V 126 (6), 1972, 617-628.
Finkelstein, R. A.; La Rue, M. K.; Lo Spalluto, J. J., "Properties of the Cholera Exo Entero Toxin Effects of Dispersing Agents and Reducing Agents in Gel Filtration and Electrophoresis", Infect. Immun. (Infib), V 6 (6), 1972, 934-944.
Fujita, K.; Finkelstein, R. A., "Anti Toxic Immunity in Experimental Cholera Comparison of Immunity Induced Per Orally and Parenterally in Mice", J. Infect. Dis. (JIDIA), V 125 (6), 1972: 647-655.
Finkelstein, R. A.; Fujita, K., "Per Orally Induced Anti Toxic Immunity Against Cholera", Fed. Proc. (FEPRA), V 31 (2), 1972: 802.
Finkelstein, R. A.; Lo Spalluto, J. J., "Crystalline Cholera Toxin and Toxoid", Science (Wash D.C.) (SCIEA), V 175 (4021), 1972: 529-530.
Lo Spalluto, J. J.; Finkelstein, R. A., "Chemical and Physical Properties of Cholera Exo-Entero-Toxin (Choleragen) and its Spontaneously Formed Toxoid (Choleragenoid)", Biochem. Biophys. ACTA (BBACAQ), V 257 (1), 1972: 158-166.
Finkelstein, R. A.; Fujita, Koichiro; Lo Spalluto, J. J., "Procholeragenoid. Aggregated Intermediate in the Formation of Choleragenoid", J. Immunol. (JDIMA3), V 107 (4), pp. 1043-1051, 1971.
Finkelstein, R. A.; Peterson, J. W.; Lo Spalluto, J. J., "Conversion of Cholera Exo-Enterotoxin (Choleragen) to Natural Toxoid (Choleragenoid)", J. Immunol., 106 3, pp. 868-871, 1971.
Finkelstein, R. A.; Lo Spalluto, J. J., "Production of Highly Purified Choleragen and Choleragenoid", J. Infec. Dis. 121 Suppl. S63-S72, 1970.
Finkelstein, R. A., "Role of Choleragen in the Pathogenesis and Immunology of Cholera", Tex. Rep. Biol. Med. 27 Suppl. 1 181-201, 1969.
Vasil, M. L.; Holmes, R. K.; Finkelstein, R. A., "Conjugal Transfer of a Chromosomal Gene Determining Production of Enterotoxin in Vibrio cholerae", Science, V 157, pp. 849-850, 1975.
Finkelstein, R. A.; Vasil, M. L.; Holmes, R. K., "Studies on Toxinogenesis in Vibrio cholerae. I. Isolation of Mutants with Altered Toxinogenicity", J. Infect. Dis. (JIDIA), V 129 (2), 1974, pp. 117-123.
Howard, Bruce D., "A Prototype Live Oral Cholera Vaccine", Nature, V 230, pp. 97-99, 1971.

Affiliated with

Also associated with

Rating

Cholera vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cholera vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cholera vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-881502